{
    "title": "US FDA approves Argenx's drug for muscle-weakening disease",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12216501/US-FDA-approves-Argenxs-therapy-muscle-weakening-disease.html",
    "date": "2023-06-20",
    "keywords": [
        "drug",
        "treatment",
        "disease",
        "company",
        "version",
        "gmg",
        "leo",
        "efgartigimod",
        "approval",
        "study",
        "argenx",
        "june",
        "food",
        "administration",
        "injection",
        "myasthenia",
        "vyvgart",
        "hytrulo",
        "month",
        "price",
        "fda",
        "brand",
        "name",
        "infusion",
        "year",
        "ingredient",
        "halozyme",
        "delivery",
        "system",
        "immune",
        "reaction",
        "body",
        "hytrulos",
        "latestage",
        "type",
        "antibody",
        "demand",
        "product",
        "use",
        "blair",
        "analyst",
        "decision",
        "minter",
        "revenue",
        "form",
        "journal",
        "medicine",
        "life",
        "target",
        "population",
        "aditya",
        "leroy",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "shilpi",
        "majumdar",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}